Pharmacologic targets on the female urethra

Urologia Internationalis

Volumn 80, Issue 4, 2008, Pages 341-354

  Canda, A Erdem ^a   Cinar, Mehtap G ^b   Turna, Burak ^b   Sahin, M Oguz ^a  

^a Manisa State Hospital   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Female urethra; Management; Pharmacology; Receptors; Stress urinary incontinence; Transmitters

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBACHOL; CARBON MONOXIDE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CLONIDINE; CYCLIC GMP; DULOXETINE; ISOPRENALINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHOSPHODIESTERASE V; PROSTANOID; RHO KINASE; SEROTONIN; SILDENAFIL; STEM CELL FACTOR; UNINDEXED DRUG;

BLADDER SPHINCTER; CELL FUNCTION; CLINICAL TRIAL; DISEASE MODEL; DRUG MECHANISM; FEMALE; HUMAN; MEDLINE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE TONE; NAUSEA; NONHUMAN; PELVIC NERVE; PELVIS FLOOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PUDENDAL NERVE; RECEPTOR INTRINSIC ACTIVITY; REVIEW; STRESS INCONTINENCE; URETHRA; URETHRA PRESSURE; URINE INCONTINENCE;

ADRENERGIC AGONISTS; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NEUROTRANSMITTER; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URETHRA; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS;

EID: 46249094184     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000132690     Document Type: Review

References (155)

1. Resnick NM: Urinary incontinence. Lancet 1995;346:94-99.
2. van der Vaart CH, de Leeuw JR, Roovers JP, et al: The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 2002;90:544-549.
3. Cetinel B, Demirkesen O, Tarcan T, et al: Hidden female urinary incontinence in urology and obstetrics and gynecology outpatient clinics in Turkey: what are the determinants of bothersome urinary incontinence and help-seeking behavior? Int Urogynecol J Pelvic Floor Dysfunct 2007;18:659-664.
4. Tanagho EA, Miller ER: Initiation of voiding. Br J Urol 1970;42:175-183.
5. Canda AE, Cross RL, Chapple CR: Pharmacology of the lower urinary tract and management of overactive bladder. J Turkish German Gynecol Assoc 2006;7:146-158.
6. Madersbacher H: Neurourology and pelvic floor dysfunction. Minerva Ginecol 2004;56:303-309.
7. Wells M: Continence following childbirth. Br J Nurs 1996;5:353-354.
8. Kölbl H: Pregnancy, childbirth and the pelvic floor. Zentralbl Gynakol 2001;123:666-671.
9. Wong MY, Harmanli OH, Agar M, Dandolu V, Grody MH: Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol 2003;189:1597-1599.
10. Elser DM, Fantl JA: Pelvic relaxation of the anterior compartment. Curr Opin Obstet Gynecol 1993;5:446-451.
11. Baessler K, Bircher MD, Stanton SL: Pelvic floor dysfunction in women after pelvic trauma. BJOG 2004;111:499-502.
12. Konstantinos H, Eleni K, Dimitrios H: Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training. Int Urol Nephrol 2006;38:513-525.
13. Harvey MA: Pelvic floor exercises during and after pregnancy: a systematic review of their role in preventing pelvic floor dysfunction. J Obstet Gynaecol Can 2003;25:451-453.
14. Perucchini D, DeLancey JO, Ashton-Miller JA, et al: Age effects on urethral striated muscle. II. Anatomic location of muscle loss. Am J Obstet Gynecol 2002;186:356-360.
15. De Groat WC: Spinal cord projections and neuropeptides in visceral afferent neurons. Prog Brain Res 1986;67:165-187.
16. Janig W, Morrison JF: Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res 1986;67:87-114.
17. de Groat WC, Downie JW, Levin RM, et al: Basic Neurophysiology and Neuropharmacology. New York, Lange, 2000, pp 457-488.
18. de Groat WC, Fraser MO, Yoshiyama M, et al: Neural control of the urethra. Scand J Urol Nephrol Suppl 2001;207:35-43.
19. Lincoln J, Burnstock G: Autonomic innervation of the urinary bladder and urethra;in Maggi CA (ed): The Autonomic Nervous System. Chapter 2. Nervous Control of the Urogenital System. London, Harwood Academic Publisher, 1993, pp 33-68.
20. Barber MD, Bremer RE, Thor KB, et al: Innervation of the female levator ani muscles. Am J Obstet Gynecol 2002;187:64-71.
21. Haab F, Zimmern PE, Leach GE: Female stress urinary incontinence due to intrinsic sphincteric deficiency: recognition and management. J Urol 1996;156:3-17.
22. Schuessler B: What do we know about duloxetine's mode of action? Evidence from animals to humans. BJOG 2006;113(suppl 1):5-9.
23. Mitterberger M, Pinggera GM, Marksteiner R, et al: Adult stem cell therapy of female stress urinary incontinence. Eur Urol 2008;53:169-175.
24. Bridgewater M, MacNeil HF, Brading AF: Regulation of tone in pig urethral smooth muscle. J Urol 1993;150:223-228.
25. Andersson KE: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993;45:253-308.
26. Appell RA, England HR, Hussell AR, et al: The effects of epidural anesthesia on the urethral closure pressure profile in patients with prostatic enlargement. J Urol 1980;124:410-411.
27. Furuya S, Kumamoto Y, Yokoyama E, et al: α -Adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 1982;128:836-839.
28. Brading AF, McCoy R, Dass N: α1-Adrenoceptors in urethral function. Eur Urol 1999;36(suppl 1):74-79.
29. Taki N, Taniguchi T, Okada K, et al: Evidence for predominant mediation of α1-adrenoceptor in the tonus of entire urethra of women. J Urol 1999;162:1829-1832.
30. Andersson KE: Neurotransmission and drug effects in urethral smooth muscle. Scand J Urol Nephrol Suppl 2001;207:26-34.
31. Daniels DV, Gever JR, Jasper JR, et al: Human cloned α1A- adrenoceptor isoforms display α1-L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 1999;370:337-343.
32. Ford AP, Daniels DV, Chang DJ, et al: Pharmacological pleiotropism of the human recombinant alpha1-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 1997;121:1127-1135.
33. Nasu K, Moriyama N, Fukasawa R, et al: Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 1998;123:1289-1293.
34. Nordling J, Meyhoff HH, Christensen NJ: Effects of clonidine (Catapresan) on urethral pressure. Invest Urol 1979;16:289-291.
35. 3H]noradrenaline secretion in guinea-pig isolated urethra. Br J Pharmacol 1992;105:142-146.
36. Bagot K, Chess-Williams R: Alpha1A/L-adrenoceptors mediate contraction of the circular smooth muscle of the pig urethra. Auton Autacoid Pharmacol 2006;26:345-353.
37. Morita T, Iizuka H, Iwata T, et al: Function and distribution of beta 3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter. J Smooth Muscle Res 2000;36:21-32.
38. Hudman D, Elliott RA, Whitaker P, et al: Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol. J Urol 2001;166:1969-1973.
39. Levin RM, Wein AJ: Quantitative analysis of alpha and beta adrenergic receptor densities in the lower urinary tract of the dog and the rabbit. Invest Urol 1979;17:75-77.
40. Van der Werf BA, Creed KE: Mechanical properties and innervation of the smooth muscle layers of the urethra of greyhounds. BJU Int 2002;90:588-595.
41. Hashimoto S, Kigoshi S, Muramatsu I: Neurogenic responses of urethra isolated from the dog. Eur J Pharmacol 1992;213:117-123.
42. Levin RM, Ruggieri MR, Wein AJ: Identification of receptor subtypes in the rabbit and human urinary bladder by selective radioligand binding. J Urol 1988;139:844-848.
43. 3- adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 1999;288:1367-1373.
44. Thind P, Lose G, Colstrup H, et al: The influence of β-adrenoceptor and muscarinic receptor agonists and antagonists on the static urethral closure function in healthy females. Scand J Urol Nephrol 1993;27:31-38.
45. Andersson KE, Appell R, Awad S, et al: Pharmacological treatment of urinary incontinence; in Abrams P, Khoury S, Wein A (eds): Incontinence, 1st International Consultation on Incontinence. Plymouth, Plymbridge Distributors Ltd, 2002, pp 479-512.
46. Yasuda K, Kawabe K, Takimoto Y, et al;the Clenbutrol Clinical Research Group: A double-blind clinical trial of a beta 2-adrenergic agonist in stress incontinence. Int Urogynecol J 1993;4:146-151.
47. Morita T, Kihara K, Nagamatsu H, et al: Effects of clenbuterol on rabbit vesicourethral muscle contractility. J Smooth Muscle Res 1995;31:119-127.
48. Yamanishi T, Chapple CR, Yasuda K, et al: The role of M2-muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra. J Urol 2002;168:308-314.
49. Yamanishi T, Yasuda K, Tojo M, Hattori T, Sakakibara R, Shimazaki J: Effects of beta 2-stimulants on contractility and fatigue of canine urethral sphincter. J Urol 1994;151:1066-1069.
50. Fujimura T, Tamura K, Tsutsumi T, et al: Expression and possible functional role of the beta3-adrenoceptor in human and rat detrusor muscle. J Urol 1999;161:680-685.
51. Yamanishi T, Chapple CR, Yasuda K, et al: The functional role of beta-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle. J Urol 2003;170:2508-2511.
52. Andersson KE: New roles for muscarinic receptors in the pathophysiology of lower urinary tract symptoms. BJU Int 2000;86:36-42.
53. Mattiasson A, Andersson KE, Andersson PO, et al: Nerve-mediated functions in the circular and longitudinal muscle layers of the proximal female rabbit urethra. J Urol 1990;143:155-160.
54. Yamanishi T, Chapple CR, Yasuda K, et al: The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivation. J Urol 2002;167:397-401.
55. Yamanishi T, Chapple CR, Yasuda K, et al: The role of M-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Br J Pharmacol 2000;131:1482-1488.
56. Wang P, Luthin GR, Ruggieri MR: Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 1995;273:959-966.
57. D'Agostino G, Bolognesi ML, Lucchelli A, et al: Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol 2000;129:493-500.
58. Sellers DJ, Yamanishi T, Chapple CR, et al: M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol 2000;20:171-176.
59. Braverman AS, Kohn IJ, Luthin GR, et al: Prejunctional M1 facilitatory and M2 inhibitory muscarinic receptors mediate rat urinary bladder contractility. Am J Physiol 1998;274:R517-523.
60. Mutoh S, Latifpour J, Saito M, et al: Evidence for the presence of regional differences in the subtype specificity of muscarinic receptors in rabbit lower urinary tract. J Urol 1997;157:717-721.
61. Nagahama K, Tsujii T, Morita T, et al: Differences between proximal and distal portions of the male rabbit posterior urethra in the physiological role of muscarinic cholinergic receptors. Br J Pharmacol 1998;124:1175-1180.
62. Ek A, Andersson KE, Ulmsten U: The effects of norephedrine and bethanechol on the human urethral closure pressure profile. Scand J Urol Nephrol 1978;12:97-104.
63. Mattiasson A, Andersson KE, Sjogren C: Adrenoceptors and cholinoceptors controlling noradrenaline release from adrenergic nerves in the urethra of rabbit and man. J Urol 1984;131:1190-1195.
64. 2+-activated K channels in bladder smooth muscle cells. Neurourol Urodyn 1998;17:400-407.
65. Hegde SS, Eglen RM: Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci 1999;64:419-428.
66. Braverman AS, Luthin GR, Ruggieri MR: M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 1998;275:R1654-R1660.
67. Braverman AS, Ruggieri MR, Pontari MA: The M2 muscarinic receptor subtype mediates cholinergic bladder contractions in patients with neurogenic bladder dysfunction. J Urol 2001;165:36-42.
68. Bradley WE: Neural control of urethrovesical function. Clin Obstet Gynecol 1978;21:653-668.
69. Birder LA, Apodoca G, de Groat WC, et al: Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 1998;275:226-229.
70. Mumtaz FH, Khan MA, Thompson CS, et al: Nitric oxide in the lower urinary tract: physiological and pathological implications. BJU Int 2000;85:567-578.
71. Mamas MA, Reynard JM, Brading AF: Nitric oxide and the lower urinary tract: current concepts, future prospects. Urology 2003;61:1079-1085.
72. Ehrén I, Iversen H, Jansson O, et al: Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses. Urology 1994;44:683-687.
73. Persson K, Alm P, Johansson K, et al: Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects. Br J Pharmacol 1993;110:521-530.
74. Triguero D, Prieto D, Garcia-Pascual A: NADPH-diaphorase and NANC relaxations are correlated in the sheep urinary tract. Neurosci Lett 1993;163:93-96.
75. Masuda H, Tsujii T, Okuno T, et al: Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract. J Urol 2002;167:2235-2240.
76. Zygmunt PM, Zygmunt PK, Högestätt ED, et al: Effects of omega-conotoxin on adrenergic, cholinergic and NANC neurotransmission in the rabbit urethra and detrusor. Br J Pharmacol 1993;110:1285-1290.
77. Förstermann U, Closs EI, Pollock JS, et al: Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-1131.
78. Burnett AL, Calvin DC, Chamness SL, et al: Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase model idiopathic voiding disorders in humans. Nat Med 1997;3:571-574.
79. Fathian-Sabet B, Bloch W, Klotz T, et al: Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol 2001;165:1724-1729.
80. Mayer B: Regulation of nitric oxide synthase and soluble guanylyl cyclase. Cell Biochem Funct 1994;12:167-177.
81. Robertson BE, Schubert R, Hescheler J, et al: cGMP-dependent protein kinase activates Ca-activated K-channels in cerebral artery smooth muscle cells. Am J Physiol 1993;265:299-303.
82. + channels in pulmonary vascular smooth muscle cells: role for nitric oxide. J Appl Physiol 1996;81:1264-1272.
83. Bolotina VM, Najibi S, Palacino JJ, et al: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-853.
84. Koh SD, Campbell AC, Carl A, et al: Nitric oxide activates multiple potassium channels in canine colonic smooth muscle. J Physiol 1995;489:735-743.
85. Warner T, Mitchell JA, Sheng H, et al: Effects of cyclic GMP on smooth muscle relaxation. Adv Pharmacol 1994;26:171-194.
86. Smet PJ, Jonavicius J, Marshall VR, et al: Distribution of nitric oxide synthase-immunoreactive nerves and identification of cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry. Neuroscience 1996;71:337-348.
87. Masuda H, Okuno T, Suzuki M, et al: Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit. J Urol 2002;168:2286-2290.
88. Werkström V, Svensson A, Andersson KE, et al: Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int 2006;98:414-423.
89. 2+ signalling in urethral interstitial cells of Cajal. J Physiol 2006;576:715-720.
90. Sergeant GP, Thornbury KD, McHale NG, et al: Characterization of norepinephrine-evoked inward currents in interstitial cells isolated from the rabbit urethra. Am J Physiol Cell Physiol 2002;283:885-894.
91. Burnstock G, Knight GE: Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004;240:31-304.
92. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-492.
93. Burnstock G: A basis for distinguishing two types of purinergic receptors;in Straub RW, Bolis L (eds): Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York, Raven Press, 1978, pp 107-118.
94. Feoktistov I, Biaggioni I: Adenosine A2B receptors. Pharmacol Rev 1997;49:381-402.
95. Fredholm BB, Ijzerman AP, Jacobson KA, et al: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-552.
96. Burnstock G, Kennedy C: Is there a basis for distinguishing two types of P2-purinoceptors? Gen Pharmacol 1985;16:433-440.
97. Kumar V, Chapple CR, Chess-Williams R: Characteristics of adenosine triphosphatase release from porcine and human normal bladder. J Urol 2004;172:744-747.
98. Dalziel HD, Westfall DP: Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol Rev 1994;46:449-466.
99. McMurray G, Dass N, Brading AF: Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle. Br J Pharmacol 1998;123:1579-1586.
100. Werkström V, Persson K, Andersson KE: NANC transmitters in the female pig urethra - localization and modulation of release via α2-adrenoceptors and potassium channels. Br J Pharmacol 1997;121:1605-1612.
101. Werkström V, Andersson KE: ATP- and adenosine-induced relaxation of the smooth muscle of the pig urethra. BJU Int 2005;96:1386-1391.
102. Callahan SM, Creed KE: Electrical and mechanical activity of the isolated lower urinary tract of the guinea-pig. Br J Pharmacol 1981;74:353-358.
103. Ohnishi N, Park YC, Kurita T, et al: Role of ATP and related purine compounds on urethral relaxation in male rabbits. Int J Urol 1997;4:191-197.
104. Pinna C, Glass R, Knight GE, et al: Purine- and pyrimidine-induced responses and P2Y receptor characterization in the hamster proximal urethra. Br J Pharmacol 2005;144:510-518.
105. Ho KM, Ny L, McMurray G, et al: Co-localization of carbon monoxide and nitric oxide synthesizing enzymes in the human urethral sphincter. J Urol 1999;161:1968-1972.
106. Sjögren C, Andersson KE, Mattiasson A: Effects of vasoactive intestinal polypeptide on isolated urethral and urinary bladder smooth muscle from rabbit and man. J Urol 1985;133:136-140.
107. Werkström V, Alm P, Persson K, et al: Inhibitory innervation of the guinea-pig urethra; roles of CO, NO, VIP. J Auton Nerv Syst 1998;74:33-42.
108. Sjögren C, Andersson KE, Andersson PO, et al: Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra. Acta Physiol Scand 1988;133:177-181.
109. Zoubek J, Somogyi GT, De Groat WC: A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra, and vas deferens. Am J Physiol 1993;265:537-543.
110. Maggi CA, Parlani M, Astolfi M, et al: Neurokinin receptors in the rat lower urinary tract. J Pharmacol Exp Ther 1988;246:308-315.
111. Maggi CA, Patacchini R: Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists. Br J Pharmacol 1992;106:888-892.
112. Parlani M, Conte B, Majmone S, et al: The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. J Urol 1990;144:1543-1545.
113. Palea S, Corsi M, Artibani W, et al: Pharmacological characterization of tachykinin NK2 receptors on isolated human urinary bladder, prostatic urethra and prostate. J Pharmacol Exp Ther 1996;277:700-705.
114. Busacchi P, Perri T, Paradisi R, et al: Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. Urology 2004;63:591-595.
115. Afiatpour P, Latifpour J, Takahashi W, et al: Developmental changes in the functional, biochemical and molecular properties of rat bladder endothelin receptors. Naunyn-Schmiedebergs Arch Pharmacol 2003;367:462-472.
116. Latifpour J, Fukumoto Y, Weiss RM: Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract. Naunyn-Schmiedebergs Arch Pharmacol 1995;352:459-468.
117. Wada Y, Latifpour J, Sanematsu H, et al: Age-related changes in contractile responses of rabbit lower urinary tract to endothelin. J Urol 2000;164:806-813.
118. Garcia-Pascual A, Larsson B, Andersson KE: Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. Acta Physiol Scand 1990;140:545-555.
119. Sullivan ME, Mumtaz FH, Khan MA, et al: Endothelins in the urinary tract. BJU Int 2000;86:97-106.
120. Andersson KE, Henriksson L, Ulmsten U: Effects of prostaglandin E2 applied locally on intravesical and intraurethral pressures in women. Eur Urol 1978;4:366-369.
121. Schussler B: Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women: a urodynamic study. Urol Res 1990;18:349-352.
122. Thor KB: Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence. Urology 2003;62(4 suppl 1):3-9.
123. Danuser H, Bemis K, Thor KB: Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat. J Urol 1995;274:820-825.
124. Thor KB, Katofiasc MA: Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthesized female cat. J Pharmacol Exp Ther 1995;274:1014-1024.
125. Katofiasc MA, Nissen J, Audia JE, et al: Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 2002;71:1227-1236.
126. Bymaster FP, Dresfield-Ahmad LJ, Threlkeld PG, et al: Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001;25:871-880.
127. Norton PA, Zinner NR, Yalcin I, et al: Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-48.
128. Dmochowski RR, Miklos JR, Norton PA, et al: Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003;170:1259-1263.
129. van Kerrebroeck P, Abrams P, Lange R, et al: Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. Br J Obstet Gynaecol 2004;111:249-257.
130. Boy S, Reitz A, Wirth B, et al: Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women. Eur Urol 2006;50:119-125.
131. Malmqvist U, Hedlund P, Sward K, et al: Female pig urethral tone is dependent on Rho guanosine triphosphatases and Rho-associated kinase. J Urol 2004;171:1955-1958.
132. Fukata Y, Mutsuki A, Kaibuchi K: Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganisation of non-muscle cells. Trends Pharmacol Sci 2001;22:32-39.
133. Hong SK, Kwak C, Chang Jeong B, et al: Involvement of Rho-kinase in the contractile mechanism of human ureteral smooth muscle. Neurourol Urodyn 2005;24:136-141.
134. Malmqvist U, Hedlund P, Sward K, et al: Female pig urethral tone is dependent on Rho guanosine triphosphatases and Rho-associated kinase. J Urol 2004;171:1955-1958.
135. Blakeman PJ, Hilton P, Bulmer JN: Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000;86:32-38.
136. Blakeman PJ, Hilton P, Bulmer JN: Cellular proliferation in the female lower urinary tract with reference to oestrogen status. BJOG 2001;108:813-816.
137. Iosif CS, Batra S, Ek A, et al: Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981;141:817-820.
138. Levin RM, Shofer FS, Wein AJ: Estrogen-induced alterations in the autonomic responses of the rabbit urinary bladder. J Pharmacol Exp Ther 1980;215:614-618.
139. Zoubina EV, Smith PG: Expression of estrogen receptors alpha and beta by sympathetic ganglion neurons projecting to the proximal urethra of female rats. J Urol 2003;169:382-385.
140. Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM: A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril 2006;85:155-160.
141. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG: Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935-948.
142. Fantl JA, Cardozo L, McClish DK: Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994;83:12-18.
143. Rosenzweig BA, Bolina PS, Birch L, et al: Location and concentration of estrogen, progesterone, and androgen receptors in the bladder and urethra of the rabbit. Neurourol Urodyn 1995;14:87-96.
144. Sajjad Y, Quenby S, Nickson P, et al: Immunohistochemical localization of androgen receptors in the urogenital tracts of human embryos. Reproduction 2004;128:331-339.
145. Toozs-Hobson P, Cutner A: Pregnancy and childbirth;in Cardozo L, Staskin D (eds): Textbook of Female Urology and Urogynaecology. Oxford, Isis Medical Media, 2001, pp 978-992.
146. Fritsch H, Pinggera GM, Lienemann A, et al: What are the supportive structures of the female urethra? Neurourol Urodyn 2006;25:128-134.
147. Häbler HJ, Jänig W, Koltzenburg M: Activation of unmyelinated afferent fibers by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol (Lond) 1990;425:545-562.
148. de Groat WC: A neurologic basis for the overactive bladder. Urology 1997;50(suppl 6A):36-52.
149. Szallasi A, Blumberg PM: Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-211.
150. Avelino A, Cruz C, Cruz F: Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application. Brain Res 2002;951:264-269.
151. Szoke E, Seress L, Szolcsanyi J: Neonatal capsaicin treatment results in prolonged mitochondrial damage and delayed cell death of B cells in the rat trigeminal ganglia. Neuroscience 2002;113:925-937.
152. Nordling L, Lundeberg T, Brolin J, Liedberg H, Ekman P, Theodorsson E: The role of sensory nerves in catheter-induced urethral inflammation. Eur Urol 1992;21:75-78.
153. De Laet K, De Wachter S, Wyndaele JJ: Current perception thresholds in the lower urinary tract: Sine- and square-wave currents studied in young healthy volunteers. Neurourol Urodyn 2005;24:261-266.
154. Kinn AC, Nilsson BY: Urethral sensitivity in incontinent women. Eur Urol 2005;48:116-120.
155. Kessler TM, Studer UE, Burkhard FC: Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn 2007;26:208-212.